Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
Details up front: GL Biochem · Chinese Peptide Company. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for…
Setup, so nobody has to ask: a 25G drawing needle · 5 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
The case in front of me: eGFR · orforglipron. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
Numbers first: a GLP-1 receptor agonist · a C8 column · survodutide. I have used one of these for a while and I am considering switching, which requires a reason.…
The case in front of me: hair thinning · tirzepatide · SURMOUNT-3. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
The case in front of me: Medutest · SWB. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
Setup, so nobody has to ask: constipation · semaglutide · STEP 2. I have read the primary source rather than the summary, which has left me with more questions. I…
Concretely: 99.4% · liraglutide. Please show the division. I want to check my own against yours. I would like the general form as well as the specific number, so I…
Conditions: two weeks · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
What I am working with: SOUL · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
The particulars: semaglutide · ESSENCE. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
Details up front: cagrilintide · sixteen weeks · 37 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
The method section is present, which is unusual enough that I want to make use of it. I am trying to build something sustainable rather than something thorough that I…
Stated plainly: STEP 1 · dizziness · 2 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
The lane and the lead time matter as much as the material for what I am doing. I want a method I can write down and repeat, not a rule of thumb. I would rather…
Details up front: 4 °C · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
What I am working with: 12.5 mg · eight weeks · nausea. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I…
The material is still sealed, so I have not committed to anything yet. This is a planning question. I know what my options are; I do not know how to weigh them. What…
Concretely: oxidation · oral semaglutide · Janoshik. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of…
For reference: 96.8% · semaglutide. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor of…
For reference: 1 mg · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules, not…
What I have: mazdutide · 40 °C · twenty-eight days. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
The case in front of me: Homopeptide · Hangzhou · Singapore. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow…
I have photographs before and after reconstitution if the visual detail matters. I am trying to do this correctly the first time rather than learn it by getting it…